Seeking Alpha

Eli Lilly (LLY) joins up with India's Strides Arcolab to sell generic cancer treatments in...

Eli Lilly (LLY) joins up with India's Strides Arcolab to sell generic cancer treatments in emerging markets. Strides will produce the medicines and Eli Lilly sell them, with the agreement initially covering 10 drugs but providing the option for more. The partnership is the latest between Big Pharma, which is seeking growth in developing markets, and Indian generic firms, which want global expertise.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|